Vera Therapeutics, Inc. announced that its ORIGIN Phase 3 trial for atacicept, a treatment for immunoglobulin A nephropathy (IgAN), achieved its primary endpoint by demonstrating a significant ...
BEIJING, Jan. 30, 2026 /PRNewswire/ -- Origin Agritech Ltd. (SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced financial results for the year ended ...
Origin Materials, Inc. Reports Operating and Financial Results for Fourth Quarter and Full Year 2024
WEST SACRAMENTO, Calif.--(BUSINESS WIRE)--Origin Materials, Inc. (“Origin,” “Origin Materials,” or the “Company”) (Nasdaq: ORGN, ORGNW), a technology ...
– Announces Review of Strategic Opportunities and New Market Segmentation to Accelerate Value Capture – – Revises Revenue and Run-Rate Adjusted EBITDA Guidance – WEST SACRAMENTO, Calif.--(BUSINESS ...
Origin Bancorp, Inc. will release its second quarter 2025 financial results on July 23, 2025, after market closure, followed by a conference call on July 24, 2025, at 8:00 a.m. Central Time. The call ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results